A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment

被引:9
作者
Janot-Sardet, Caroline [1 ]
Assouline, Brigitte [1 ]
Cheynier, Remi [2 ]
Morre, Michel [1 ]
Beq, Stephanie [1 ]
机构
[1] Cytheris SA, Technopolis, F-92130 Issy Les Moulineaux, France
[2] Inst Pasteur, Dept Virol, F-75015 Paris, France
关键词
Interleukin; 7; Soluble CD127; ELISA; TSLP1; CD127; STIMULATES TYROSINE PHOSPHORYLATION; INOSITOL PHOSPHOLIPID TURNOVER; T-CELL DEPLETION; INTERLEUKIN-7; RECEPTOR; IN-VIVO; HUMAN PLASMA; EXPRESSION; EXPANSION; NAIVE; INFECTION;
D O I
10.1016/j.jim.2009.12.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
IL-7 is a crucial cytokine for T cell hematopoiesis and peripheral homeostasis which by signaling through its receptor alpha chain (CD127) is essential for inducing T cell proliferation and survival. Since the specific CD127 alpha chain is found in a soluble state (sCD127) and at a high level in plasma (ng/mL), it is important to develop a sensitive and reliable assay in order to investigate the potential role of this receptor in the regulation of IL-7 physiologic, physipathologic and therapeutic effects. We here report a fully validated method to measure sCD127 in human and simian plasma using a method based on ELISA MSD technology. We demonstrate that sCD127 is detectable at various levels in the plasma of healthy humans as well as in that of healthy Rhesus and Cynomolgus macaques (106.72, 205.26 and 366.95 ng/mL respectively). Moreover, as opposed to the sCD25/IL-2 tandem, we demonstrate that IL-7 treatment has no impact on sCD127 plasma concentration in patients infected by HIV. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 44 条
  • [1] Al-Rawi MAA, 2003, HISTOL HISTOPATHOL, V18, P911, DOI 10.14670/HH-18.911
  • [2] ARMITAGE RJ, 1992, BLOOD, V79, P1738
  • [3] Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques
    Beq, Stephanie
    Rozlan, Sandra
    Gautier, David
    Parker, Raphaelle
    Mersseman, Veronique
    Schilte, Clementine
    Assouline, Brigitte
    Rance, Iann
    Lavedan, Pascal
    Morre, Michel
    Cheynier, Remi
    [J]. BLOOD, 2009, 114 (04) : 816 - 825
  • [4] Soluble IL-7Ralpha (sCD127) and Measurement of IL-7 in the Plasma of HIV Patients
    Blom-Potar, Marie-Christine
    Bugault, Florence
    Lambotte, Olivier
    Delfraissy, Jean-Francois
    Theze, Jacques
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (01) : 104 - 105
  • [5] SERUM CD25 LEVELS DURING INTERLEUKIN-2 THERAPY - DOSE DEPENDENCE AND CORRELATIONS WITH CLINICAL TOXICITY AND LYMPHOCYTE SURFACE SCD25 EXPRESSION
    BOGNER, MP
    VOSS, SD
    BECHHOFER, R
    HANK, JA
    ROPER, M
    POPLACK, D
    HAMMOND, D
    SONDEL, PM
    [J]. JOURNAL OF IMMUNOTHERAPY, 1992, 11 (02): : 111 - 118
  • [6] Bolotin E, 1996, BLOOD, V88, P1887
  • [7] Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer
    De Vita, F
    Turitto, G
    di Grazia, M
    Frattolillo, A
    Catalano, G
    [J]. TUMORI JOURNAL, 1998, 84 (01): : 33 - 38
  • [8] Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules
    DeSilva, B
    Smith, W
    Weiner, R
    Kelley, M
    Smolec, JM
    Lee, B
    Khan, M
    Tacey, R
    Hill, H
    Celniker, A
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (11) : 1885 - 1900
  • [9] Esnault S, 2008, INT J CLIN EXP PATHO, V1, P325
  • [10] BIOSPECIFIC INTERACTION ANALYSIS USING SURFACE-PLASMON RESONANCE DETECTION APPLIED TO KINETIC, BINDING-SITE AND CONCENTRATION ANALYSIS
    FAGERSTAM, LG
    FROSTELLKARLSSON, A
    KARLSSON, R
    PERSSON, B
    RONNBERG, I
    [J]. JOURNAL OF CHROMATOGRAPHY, 1992, 597 (1-2): : 397 - 410